Deng, S. et al. RNA m(6)A regulates transcription via DNA demethylation and chromatin accessibility. Nat. Genet. 54, 1427–1437 (2022).
Google Scholar
Takahashi, M. et al. The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the STING-IFN-β pathway. Nat. Immunol. 22, 485–496 (2021).
Google Scholar
Karikó, K., Buckstein, M., Ni, H. & Weissman, D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165–175 (2005).
Google Scholar
Yoon, K. J. et al. Temporal control of mammalian cortical neurogenesis by m(6)A methylation. Cell 171, 877–889.e817 (2017).
Google Scholar
Guzzi, N. et al. Pseudouridylation of tRNA-derived fragments steers translational control in stem cells. Cell 173, 1204–1216.e1226 (2018).
Google Scholar
Rapino, F. et al. Codon-specific translation reprogramming promotes resistance to targeted therapy. Nature 558, 605–609 (2018).
Google Scholar
Liu, Y. et al. tRNA-m(1)A modification promotes T cell expansion via efficient MYC protein synthesis. Nat. Immunol. 23, 1433–1444 (2022).
Google Scholar
Yankova, E. et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature 593, 597–601 (2021).
Google Scholar
Delaunay, S. et al. Mitochondrial RNA modifications shape metabolic plasticity in metastasis. Nature 607, 593–603 (2022).
Google Scholar
Liu, H. et al. Targeting tumour-intrinsic N(7)-methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacy. Gut 72, 1555–1567 (2023).
Google Scholar
Jones, P. A., Issa, J.-P. J. & Baylin, S. Targeting the cancer epigenome for therapy. Nat. Rev. Genet. 17, 630–641 (2016).
Google Scholar
Barbieri, I. & Kouzarides, T. Role of RNA modifications in cancer. Nat. Rev. Cancer 20, 303–322 (2020).
Google Scholar
Bartee, D., Thalalla Gamage, S., Link, C. N. & Meier, J. L. Arrow pushing in RNA modification sequencing. Chem. Soc. Rev. 50, 9482–9502 (2021).
Google Scholar
Wiener, D. & Schwartz, S. The epitranscriptome beyond m(6)A. Nat. Rev. Genet. 22, 119–131 (2021).
Google Scholar
Boccaletto, P. et al. MODOMICS: a database of RNA modification pathways. 2017 update. Nucleic Acids Res. 46, D303–d307 (2018).
Google Scholar
Liu, N. et al. N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions. Nature 518, 560–564 (2015).
Google Scholar
Alarcón, C. R. et al. HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events. Cell 162, 1299–1308 (2015).
Google Scholar
Wang, X. et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature 505, 117–120 (2014).
Google Scholar
Chen, X. et al. 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. Nat. Cell Biol. 21, 978–990 (2019).
Google Scholar
Yang, X. et al. 5-methylcytosine promotes mRNA export – NSUN2 as the methyltransferase and ALYREF as an m(5)C reader. Cell Res. 27, 606–625 (2017).
Google Scholar
Yang, Y. et al. RNA 5-methylcytosine facilitates the maternal-to-zygotic transition by preventing maternal mRNA decay. Mol. Cell 75, 1188–1202.e1111 (2019).
Google Scholar
Zhang, Y. et al. Dnmt2 mediates intergenerational transmission of paternally acquired m etabolic disorders through sperm small non-coding RNAs. Nat. Cell Biol. 20, 535–540 (2018).
Google Scholar
Dominissini, D. et al. The dynamic N(1)-methyladenosine methylome in eukaryotic messenger RNA. Nature 530, 441–446 (2016).
Google Scholar
Wu, Y. et al. RNA m(1)A methylation regulates glycolysis of cancer cells through modulating ATP5D. Proc. Natl. Acad. Sci. USA 119, e2119038119 (2022).
Google Scholar
Feng, Z. et al. The LINC00623/NAT10 signaling axis promotes pancreatic cancer progress ion by remodeling ac4C modification of mRNA. J. Hematol. Oncol. J. Hematol Oncol 15, 112 (2022).
Google Scholar
Carlile, T. M. et al. Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human cells. Nature 515, 143–146 (2014).
Google Scholar
Ohira, T. et al. Reversible RNA phosphorylation stabilizes tRNA for cellular thermotolerance. Nature 605, 372–379 (2022).
Google Scholar
Alexandrov, A. et al. Rapid tRNA decay can result from lack of nonessential modifications. Mol. Cell 21, 87–96 (2006).
Google Scholar
Van Haute, L. et al. NSUN2 introduces 5-methylcytosines in mammalian mitochondrial tRNAs. Nucleic Acids Res. 47, 8720–8733 (2019).
Google Scholar
Morscher, R. J. et al. Mitochondrial translation requires folate-dependent tRNA methylation. Nature 554, 128–132 (2018).
Google Scholar
Suzuki, T. The expanding world of tRNA modifications and their disease relevance. Nat. Rev. Mol. Cell Biol. 22, 375–392 (2021).
Google Scholar
Sharma, S. & Lafontaine, D. L. J. ‘View from a bridge’: a new perspective on eukaryotic rRNA base modification. Trends Biochem. Sci. 40, 560–575 (2015).
Google Scholar
Liu, H. T. et al. lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus. Cell Death Differ. 29, 627–641 (2022).
Google Scholar
Li, Z. X. et al. WTAP-mediated m(6)A modification of lncRNA DIAPH1-AS1 enhances its stability to facilitate nasopharyngeal carcinoma growth and metastasis. Cell Death Differ. 29, 1137–1151 (2022).
Google Scholar
Chen, R. X. et al. N(6)-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis. Nat. Commun. 10, 4695 (2019).
Google Scholar
Wang, J. X. et al. Oxidative modification of miR-184 enables it to target Bcl-xL and Bcl-w. Mol. Cell 59, 50–61 (2015).
Google Scholar
Jones, M. R. et al. Zcchc11-dependent uridylation of microRNA directs cytokine expression. Nat. Cell Biol. 11, 1157–1163 (2009).
Google Scholar
Fan, J. et al. Long non-coding RNA ROR decoys gene-specific histone methylation to promote tumorigenesis. Genome Biol. 16, 139 (2015).
Google Scholar
Sun, T. T. et al. LncRNA GClnc1 promotes gastric carcinogenesis and may act as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern. Cancer Discov. 6, 784–801 (2016).
Google Scholar
Tsai, M.-C. et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 329, 689–693 (2010).
Google Scholar
Wei, C. M., Gershowitz, A. & Moss, B. Methylated nucleotides block 5’ terminus of HeLa cell messenger RNA. Cell 4, 379–386 (1975).
Google Scholar
Furuichi, Y. et al. Methylated, blocked 5 termini in HeLa cell mRNA. Proc. Natl. Acad. Sci. USA 72, 1904–1908 (1975).
Google Scholar
Dominissini, D. et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485, 201–206 (2012).
Google Scholar
Meyer, K. D. et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3’ UTRs and near stop codons. Cell 149, 1635–1646 (2012).
Google Scholar
Zaccara, S., Ries, R. J. & Jaffrey, S. R. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol 20, 608–624 (2019).
Google Scholar
Liu, J. et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat. Chem. Biol. 10, 93–95 (2014).
Google Scholar
Bokar, J. A., Shambaugh, M. E., Polayes, D., Matera, A. G. & Rottman, F. M. Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase. RNA 3, 1233–1247 (1997).
Google Scholar
Ping, X. L. et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 24, 177–189 (2014).
Google Scholar
Wang, P., Doxtader, K. A. & Nam, Y. Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol. Cell 63, 306–317 (2016).
Google Scholar
Wang, X. et al. Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex. Nature 534, 575–578 (2016).
Google Scholar
Warda, A. S. et al. Human METTL16 is a N(6)-methyladenosine (m(6)A) methyltransferase that targets pre-mRNAs and various non-coding RNAs. EMBO Rep. 18, 2004–2014 (2017).
Google Scholar
Yue, Y. et al. VIRMA mediates preferential m(6)A mRNA methylation in 3’UTR and near stop codon and associates with alternative polyadenylation. Cell Discov. 4, 10 (2018).
Google Scholar
Patil, D. P. et al. m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature 537, 369–373 (2016).
Google Scholar
van Tran, N. et al. The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112. Nucleic Acids Res. 47, 7719–7733 (2019).
Google Scholar
Harper, J. E., Miceli, S. M., Roberts, R. J. & Manley, J. L. Sequence specificity of the human mRNA N6-adenosine methylase in vitro. Nucleic Acids Res. 18, 5735–5741 (1990).
Google Scholar
Csepany, T., Lin, A., Baldick, C. J. Jr. & Beemon, K. Sequence specificity of mRNA N6-adenosine methyltransferase. J. Biol. Chem. 265, 20117–20122 (1990).
Google Scholar
Bokar, J. A., Rath-Shambaugh, M. E., Ludwiczak, R., Narayan, P. & Rottman, F. Characterization and partial purification of mRNA N6-adenosine methyltransferase from HeLa cell nuclei. Internal mRNA methylation requires a multisubunit complex. J. Biol. Chem. 269, 17697–17704 (1994).
Google Scholar
Jia, G. et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat. Chem. Biol. 7, 885–887 (2011).
Google Scholar
Zheng, G. et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol. Cell 49, 18–29 (2013).
Google Scholar
Zhao, X. et al. FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis. Cell Res. 24, 1403–1419 (2014).
Google Scholar
Bartosovic, M. et al. N6-methyladenosine demethylase FTO targets pre-mRNAs and regulates alternative splicing and 3’-end processing. Nucleic Acids Res. 45, 11356–11370 (2017).
Google Scholar
Xiao, W. et al. Nuclear m(6)A reader YTHDC1 regulates mRNA splicing. Mol. Cell 61, 507–519 (2016).
Google Scholar
Li, S. et al. Nuclear Aurora kinase A switches m(6)A reader YTHDC1 to enhance an oncogenic RNA splicing of tumor suppressor RBM4. Signal Transduct. Target. Ther. 7, 97 (2022).
Google Scholar
Chen, L. et al. Nuclear m(6) A reader YTHDC1 suppresses proximal alternative polyadenylation sites by interfering with the 3’ processing machinery. EMBO Rep. 23, e54686 (2022).
Google Scholar
Kasowitz, S. D. et al. Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development. PLoS Genet. 14, e1007412 (2018).
Google Scholar
Sun, S. et al. RNA binding protein NKAP protects glioblastoma cells from ferroptosis by promoting SLC7A11 mRNA splicing in an m(6)A-dependent manner. Cell Death Dis. 13, 73 (2022).
Google Scholar
Alarcón, C. R., Lee, H., Goodarzi, H., Halberg, N. & Tavazoie, S. F. N6-methyladenosine marks primary microRNAs for processing. Nature 519, 482–485 (2015).
Google Scholar
Zhang, J. et al. Excessive miR-25-3p maturation via N(6)-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression. Nat. Commun. 10, 1858 (2019).
Google Scholar
Ma, J. Z. et al. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6) -methyladenosine-dependent primary MicroRNA processing. Hepatology 65, 529–543 (2017).
Google Scholar
Liu, Z. et al. A methyltransferase-like 14/miR-99a-5p/tribble 2 positive feedback circuit promotes cancer stem cell persistence and radioresistance via histone deacetylase 2-mediated epigenetic modulation in esophageal squamous cell carcinoma. Clin. Transl. Med. 11, e545 (2021).
Google Scholar
Liu, N. et al. N6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein. Nucleic Acids Res. 45, 6051–6063 (2017).
Google Scholar
Zhou, K. I. et al. Regulation of co-transcriptional pre-mRNA splicing by m(6)A through the low-complexity protein hnRNPG. Mol. Cell 76, 70–81.e79 (2019).
Google Scholar
Pendleton, K. E. et al. The U6 snRNA m(6)A Methyltransferase METTL16 Regulates SAM Synthetase Intron Retention. Cell 169, 824–835.e814 (2017).
Google Scholar
Aoyama, T., Yamashita, S. & Tomita, K. Mechanistic insights into m6A modification of U6 snRNA by human METTL16. Nucleic Acids Res. 48, 5157–5168 (2020).
Google Scholar
Tang, C. et al. ALKBH5-dependent m6A demethylation controls splicing and stability of long 3’-UTR mRNAs in male germ cells. Proc. Natl. Acad. Sci. USA 115, E325–e333 (2018).
Google Scholar
Wei, G. et al. Acute depletion of METTL3 implicates N (6)-methyladenosine in alternative intron/exon inclusion in the nascent transcriptome. Genome Res. 31, 1395–1408 (2021).
Google Scholar
Roundtree, I. A. et al. YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs. Elife 6, e31311 (2017).
Google Scholar
Chen, X. et al. m(6)A modification of circSPECC1 suppresses RPE oxidative damage and maintains retinal homeostasis. Cell Rep. 41, 111671 (2022).
Google Scholar
Edens, B. M. et al. FMRP modulates neural differentiation through m(6)A-dependent mRNA nuclear export. Cell Rep 28, 845–854.e845 (2019).
Google Scholar
Batista, P. J. et al. m(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell 15, 707–719 (2014).
Google Scholar
Ke, S. et al. A majority of m6A residues are in the last exons, allowing the potential for 3’ UTR regulation. Genes Dev 29, 2037–2053 (2015).
Google Scholar
Slobodin, B. et al. Transcription dynamics regulate poly(A) tails and expression of the RNA degradation machinery to balance mRNA levels. Mol. Cell 78, 434–444.e435 (2020).
Google Scholar
Du, H. et al. YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex. Nat. Commun. 7, 12626 (2016).
Google Scholar
Liu, L. et al. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma. Clin. Transl. Med. 12, e778 (2022).
Google Scholar
Zhang, G. et al. Dynamic FMR1 granule phase switch instructed by m6A modification contributes to maternal RNA decay. Nat. Commun. 13, 859 (2022).
Google Scholar
Li, F. et al. N(6)-methyladenosine modulates nonsense-mediated mRNA Decay in human glioblastoma. Cancer Res. 79, 5785–5798 (2019).
Google Scholar
Liu, J. et al. N (6)-methyladenosine of chromosome-associated regulatory RNA regulates chromatin state and transcription. Science 367, 580–586 (2020).
Google Scholar
Cheng, Y. et al. N(6)-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation. Cancer Cell 39, 958–972.e958 (2021).
Google Scholar
Wojtas, M. N. et al. Regulation of m(6)A transcripts by the 3’→5’ RNA helicase YTHDC2 is essential for a successful meiotic program in the mammalian germline. Mol. Cell 68, 374–387.e312 (2017).
Google Scholar
Jin, D. et al. m(6)A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC. Mol. Cancer 19, 40 (2020).
Google Scholar
Zhou, C. et al. Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs. Cell Rep. 20, 2262–2276 (2017).
Google Scholar
Shi, H. et al. YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA. Cell Res. 27, 315–328 (2017).
Google Scholar
Zaccara, S. & Jaffrey, S. R. A unified model for the function of YTHDF proteins in regulating m(6)A-modified mRNA. Cell 181, 1582–1595.e1518 (2020).
Google Scholar
Lasman, L. et al. Context-dependent functional compensation between Ythdf m(6)A reader proteins. Genes Dev. 34, 1373–1391 (2020).
Google Scholar
Xia, T. L. et al. N(6)-methyladenosine-binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay. EMBO Rep. 22, e50128 (2021).
Google Scholar
Li, J. et al. YTHDF1 promotes mRNA degradation via YTHDF1-AGO2 interaction and phase separation. Cell Prolif 55, e13157 (2022).
Google Scholar
Ni, W. et al. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m(6)A reader YTHDF3. Mol. Cancer 18, 143 (2019).
Google Scholar
Hu, Y. et al. A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of miR-5586-5p. J. Exp. Clin. Cancer Res. 41, 69 (2022).
Google Scholar
Zhang, F. et al. Fragile X mental retardation protein modulates the stability of its m6A-marked messenger RNA targets. Hum. Mol. Genet. 27, 3936–3950 (2018).
Google Scholar
Zhu, Y. et al. LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability. Clin. Transl. Med. 12, e703 (2022).
Google Scholar
Huang, H. et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat. Cell Biol. 20, 285–295 (2018).
Google Scholar
Zhu, S. et al. An oncopeptide regulates m(6)A recognition by the m(6)A reader IGF2BP1 and tumorigenesis. Nat. Commun. 11, 1685 (2020).
Google Scholar
Bechara, R. et al. The m(6)A reader IMP2 directs autoimmune inflammation through an IL-17- and TNFα-dependent C/EBP transcription factor axis. Sci. Immunol. 6, eabd1287 (2021).
Google Scholar
Müller, S. et al. IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner. Nucleic Acids Res. 47, 375–390 (2019).
Google Scholar
Müller, S. et al. The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer. Nucleic Acids Res. 48, 8576–8590 (2020).
Google Scholar
Liu, Y. et al. LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma. J. Hematol. Oncol. 15, 52 (2022).
Google Scholar
Zhou, L. et al. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m(6)A-mediated degradation of STEAP3 mRNA. Mol. Cancer 21, 168 (2022).
Google Scholar
Chen, Z. et al. rtcisE2F promotes the self-renewal and metastasis of liver tumor-initiating cells via N(6)-methyladenosine-dependent E2F3/E2F6 mRNA stability. Sci. China Life Sci. 65, 1840–1854 (2022).
Google Scholar
Yang, H. et al. Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer. J. Adv. Res. 37, 91–106 (2022).
Google Scholar
Zhu, P. et al. A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability. Oncogene 40, 1609–1627 (2021).
Google Scholar
Yang, L. et al. Hsa_circ_0004287 inhibits macrophage-mediated inflammation in an N(6)-methyladenosine-dependent manner in atopic dermatitis and psoriasis. J. Allergy Clin. Immunol. 149, 2021–2033 (2022).
Google Scholar
Chen, Y. et al. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Mol. Cancer 18, 127 (2019).
Google Scholar
Yue, B. et al. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer. Mol. Cancer 18, 142 (2019).
Google Scholar
Lan, T. et al. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3. Mol. Cancer 18, 186 (2019).
Google Scholar
Zhang, Y. et al. The m(6)A demethylase ALKBH5-mediated upregulation of DDIT4-AS1 maintains pancreatic cancer stemness and suppresses chemosensitivity by activating the mTOR pathway. Mol. Cancer 21, 174 (2022).
Google Scholar
Wang, Y. et al. N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells. Nat. Cell Biol. 16, 191–198 (2014).
Google Scholar
Edupuganti, R. R. et al. N(6)-methyladenosine (m(6)A) recruits and repels proteins to regulate mRNA homeostasis. Nat. Struct. Mol. Biol. 24, 870–878 (2017).
Google Scholar
Leppek, K., Das, R. & Barna, M. Functional 5’ UTR mRNA structures in eukaryotic translation regulation and how to find them. Nat. Rev. Mol. Cell Biol. 19, 158–174 (2018).
Google Scholar
Ishigaki, Y., Li, X., Serin, G. & Maquat, L. E. Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20. Cell 106, 607–617 (2001).
Google Scholar
Lin, S., Choe, J., Du, P., Triboulet, R. & Gregory, R. I. The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol. Cell 62, 335–345 (2016).
Google Scholar
Choe, J. et al. mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis. Nature 561, 556–560 (2018).
Google Scholar
Su, R. et al. METTL16 exerts an m(6)A-independent function to facilitate translation and tumorigenesis. Nat. Cell Biol. 24, 205–216 (2022).
Google Scholar
Wang, F. et al. METTL16 promotes translation and lung tumorigenesis by sequestering cytoplasmic eIF4E2. Cell Rep. 42, 112150 (2023).
Google Scholar
Wang, X. et al. N(6)-methyladenosine modulates messenger RNA translation efficiency. Cell 161, 1388–1399 (2015).
Google Scholar
Lin, X. et al. RNA m(6)A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail. Nat. Commun. 10, 2065 (2019).
Google Scholar
Mao, Y. et al. m(6)A in mRNA coding regions promotes translation via the RNA helicase-containing YTHDC2. Nat. Commun. 10, 5332 (2019).
Google Scholar
Li, A. et al. Cytoplasmic m(6)A reader YTHDF3 promotes mRNA translation. Cell Res. 27, 444–447 (2017).
Google Scholar
Coots, R. A. et al. m(6)A facilitates eIF4F-independent mRNA translation. Mol. Cell 68, 504–514.e507 (2017).
Google Scholar
Yang, Y. et al. Extensive translation of circular RNAs driven by N(6)-methyladenosine. Cell Res. 27, 626–641 (2017).
Google Scholar
Meyer, K. D. et al. 5’ UTR m(6)A promotes cap-independent translation. Cell 163, 999–1010 (2015).
Google Scholar
Ma, H. et al. N(6-)Methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation. Nat. Chem. Biol. 15, 88–94 (2019).
Google Scholar
Pinto, R. et al. The human methyltransferase ZCCHC4 catalyses N6-methyladenosine modification of 28S ribosomal RNA. Nucleic Acids Res. 48, 830–846 (2020).
Google Scholar
Ignatova, V. V. et al. The rRNA m(6)A methyltransferase METTL5 is involved in pluripotency and developmental programs. Genes Dev. 34, 715–729 (2020).
Google Scholar
Rong, B. et al. Ribosome 18S m(6)A methyltransferase METTL5 promotes translation initiation and breast cancer cell growth. Cell Rep. 33, 108544 (2020).
Google Scholar
Choi, J. et al. N(6)-methyladenosine in mRNA disrupts tRNA selection and translation-elongation dynamics. Nat. Struct. Mol. Biol. 23, 110–115 (2016).
Google Scholar
Grozhik, A. V. et al. Antibody cross-reactivity accounts for widespread appearance of m(1)A in 5’UTRs. Nat. Commun. 10, 5126 (2019).
Google Scholar
Bar-Yaacov, D. et al. Mitochondrial 16S rRNA is methylated by tRNA methyltransferase TRMT61B in all vertebrates. PLoS Biol. 14, e1002557 (2016).
Google Scholar
Chujo, T. & Suzuki, T. Trmt61B is a methyltransferase responsible for 1-methyladenosine at position 58 of human mitochondrial tRNAs. RNA 18, 2269–2276 (2012).
Google Scholar
Vilardo, E. et al. A subcomplex of human mitochondrial RNase P is a bifunctional methyltransferase–extensive moonlighting in mitochondrial tRNA biogenesis. Nucleic Acids Res. 40, 11583–11593 (2012).
Google Scholar
Li, X. et al. Base-resolution mapping reveals distinct m(1)A methylome in nuclear- and mitochondrial-encoded transcripts. Mol. Cell 68, 993–1005.e1009 (2017).
Google Scholar
Safra, M. et al. The m1A landscape on cytosolic and mitochondrial mRNA at single-base resolution. Nature 551, 251–255 (2017).
Google Scholar
Li, X. et al. Transcriptome-wide mapping reveals reversible and dynamic N(1)-methyladenosine methylome. Nat. Chem. Biol. 12, 311–316 (2016).
Google Scholar
Woo, H. H. & Chambers, S. K. Human ALKBH3-induced m(1)A demethylation increases the CSF-1 mRNA stability in breast and ovarian cancer cells. Biochim. Biophys. Acta Gene Regul. Mech. 1862, 35–46 (2019).
Google Scholar
Kuang, W. et al. ALKBH3-dependent m(1)A demethylation of Aurora A mRNA inhibits ciliogenesis. Cell Discov. 8, 25 (2022).
Google Scholar
Chen, Z. et al. Transfer RNA demethylase ALKBH3 promotes cancer progression via induction of tRNA-derived small RNAs. Nucleic Acids Res. 47, 2533–2545 (2019).
Google Scholar
Liu, F. et al. ALKBH1-mediated tRNA demethylation regulates translation. Cell 167, 816–828.e816 (2016).
Google Scholar
Zhang, L. S. et al. ALKBH7-mediated demethylation regulates mitochondrial polycistronic RNA processing. Nat. Cell Biol. 23, 684–691 (2021).
Google Scholar
Wei, J. et al. Differential m(6)A, m(6)A(m), and m(1)A demethylation mediated by FTO in the cell nucleus and cytoplasm. Mol. Cell 71, 973–985.e975 (2018).
Google Scholar
Guo, G. et al. Advances in mRNA 5-methylcytosine modifications: Detection, effectors, biological functions, and clinical relevance. Mol. Ther. Nucleic Acids 26, 575–593 (2021).
Google Scholar
Squires, J. E. et al. Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA. Nucleic Acids Res. 40, 5023–5033 (2012).
Google Scholar
Huang, T., Chen, W., Liu, J., Gu, N. & Zhang, R. Genome-wide identification of mRNA 5-methylcytosine in mammals. Nat. Struct. Mol. Biol. 26, 380–388 (2019).
Google Scholar
Van Haute, L. et al. Deficient methylation and formylation of mt-tRNA(Met) wobble cytosine in a patient carrying mutations in NSUN3. Nat. Commun 7, 12039 (2016).
Google Scholar
Liu, R. J., Long, T., Li, J., Li, H. & Wang, E. D. Structural basis for substrate binding and catalytic mechanism of a human RNA:m5C methyltransferase NSun6. Nucleic Acids Res. 45, 6684–6697 (2017).
Google Scholar
Huang, Z. X. et al. Position 34 of tRNA is a discriminative element for m5C38 modification by human DNMT2. Nucleic Acids Res. 49, 13045–13061 (2021).
Google Scholar
Janin, M. et al. Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program. Acta Neuropathol. 138, 1053–1074 (2019).
Google Scholar
Liao, H. et al. Human NOP2/NSUN1 regulates ribosome biogenesis through non-catalytic complex formation with box C/D snoRNPs. Nucleic Acids Res. 50, 10695–10716 (2022).
Google Scholar
Yang, L. et al. Nsun4 and Mettl3 mediated translational reprogramming of Sox9 promotes BMSC chondrogenic differentiation. Commun. Biol. 5, 495 (2022).
Google Scholar
Spåhr, H., Habermann, B., Gustafsson, C. M., Larsson, N. G. & Hallberg, B. M. Structure of the human MTERF4-NSUN4 protein complex that regulates mitochondrial ribosome biogenesis. Proc. Natl. Acad. Sci. USA 109, 15253–15258 (2012).
Google Scholar
Dai, X. et al. YTHDF2 Binds to 5-Methylcytosine in RNA and Modulates the Maturation of Ribosomal RNA. Anal. Chem. 92, 1346–1354 (2020).
Google Scholar
Arguello, A. E. et al. Reactivity-dependent profiling of RNA 5-methylcytidine dioxygenases. Nat. Commun. 13, 4176 (2022).
Google Scholar
Huang, W. et al. Formation and determination of the oxidation products of 5-methylcytosine in RNA. Chem. Sci. 7, 5495–5502 (2016).
Google Scholar
Fu, L. et al. Tet-mediated formation of 5-hydroxymethylcytosine in RNA. J. Am. Chem. Soc. 136, 11582–11585 (2014).
Google Scholar
Xue, C. et al. ALYREF mediates RNA m(5)C modification to promote hepatocellular carcinoma progression. Signal Transduct. Target. Ther. 8, 130 (2023).
Google Scholar
Shen, Q. et al. Tet2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation. Nature 554, 123–127 (2018).
Google Scholar
Yang, W. L. et al. Nsun2 coupling with RoRγt shapes the fate of Th17 cells and promotes colitis. Nat. Commun. 14, 863 (2023).
Google Scholar
Muthukrishnan, S., Both, G. W., Furuichi, Y. & Shatkin, A. J. 5′-Terminal 7-methylguanosine in eukaryotic mRNA is required for translation. Nature 255, 33–37 (1975).
Google Scholar
Adams, J. M. & Cory, S. Modified nucleosides and bizarre 5′-termini in mouse myeloma mRNA. Nature 255, 28–33 (1975).
Google Scholar
Aregger, M. et al. CDK1-cyclin B1 activates RNMT, coordinating mRNA cap methylation with G1 phase transcription. Mol. Cell 61, 734–746 (2016).
Google Scholar
Létoquart, J. et al. Structural and functional studies of Bud23-Trm112 reveal 18S rRNA N7-G1575 methylation occurs on late 40S precursor ribosomes. Proc. Natl. Acad. Sci. USA 111, E5518–E5526 (2014).
Google Scholar
Pandolfini, L. et al. METTL1 promotes let-7 microRNA processing via m7G methylation. Mol. Cell 74, 1278–1290.e1279 (2019).
Google Scholar
Dai, Z. et al. N(7)-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression. Mol. Cell 81, 3339–3355.e3338 (2021).
Google Scholar
Zhang, L. S. et al. Transcriptome-wide mapping of internal N(7)-methylguanosine methylome in mammalian mRNA. Mol. Cell 74, 1304–1316.e1308 (2019).
Google Scholar
Furuichi, Y., LaFiandra, A. & Shatkin, A. J. 5’-Terminal structure and mRNA stability. Nature 266, 235–239 (1977).
Google Scholar
Konarska, M. M., Padgett, R. A. & Sharp, P. A. Recognition of cap structure in splicing in vitro of mRNA precursors. Cell 38, 731–736 (1984).
Google Scholar
Hsu, C. L. & Stevens, A. Yeast cells lacking 5’–>3’ exoribonuclease 1 contain mRNA species that are poly(A) deficient and partially lack the 5’ cap structure. Mol. Cell. Biol. 13, 4826–4835 (1993).
Google Scholar
Pabis, M. et al. The nuclear cap-binding complex interacts with the U4/U6·U5 tri-snRNP and promotes spliceosome assembly in mammalian cells. RNA 19, 1054–1063 (2013).
Google Scholar
Niedzwiecka, A. et al. Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5’ cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins. J. Mol. Biol. 319, 615–635 (2002).
Google Scholar
Kiriakidou, M. et al. An mRNA m7G cap binding-like motif within human Ago2 represses translation. Cell 129, 1141–1151 (2007).
Google Scholar
Pillai, R. S. et al. Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 309, 1573–1576 (2005).
Google Scholar
Lin, S. et al. Mettl1/Wdr4-mediated m(7)G tRNA methylome is required for normal mRNA translation and embryonic stem cell self-renewal and differentiation. Mol. Cell 71, 244–255.e245 (2018).
Google Scholar
Ma, J. et al. METTL1/WDR4-mediated m(7)G tRNA modifications and m(7)G codon usage promote mRNA translation and lung cancer progression. Mol. Ther. 29, 3422–3435 (2021).
Google Scholar
Culjkovic, B., Topisirovic, I., Skrabanek, L., Ruiz-Gutierrez, M. & Borden, K. L. eIF4E promotes nuclear export of cyclin D1 mRNAs via an element in the 3’UTR. J. Cell Biol. 169, 245–256 (2005).
Google Scholar
Xie, M. et al. Mammalian 5’-capped microRNA precursors that generate a single microRNA. Cell 155, 1568–1580 (2013).
Google Scholar
Sheng, P. et al. Dicer cleaves 5’-extended microRNA precursors originating from RNA polymerase II transcription start sites. Nucleic Acids Res. 46, 5737–5752 (2018).
Google Scholar
Dantsuji, S., Ohno, M. & Taniguchi, I. The hnRNP C tetramer binds to CBC on mRNA and impedes PHAX recruitment for the classification of RNA polymerase II transcripts. Nucleic Acids Res. 51, 1393–1408 (2023).
Google Scholar
Ito, S. et al. Human NAT10 is an ATP-dependent RNA acetyltransferase responsible for N4-acetylcytidine formation in 18 S ribosomal RNA (rRNA). J. Biol. Chem. 289, 35724–35730 (2014).
Google Scholar
Bortolin-Cavaillé, M. L. et al. Probing small ribosomal subunit RNA helix 45 acetylation across eukaryotic evolution. Nucleic Acids Res. 50, 6284–6299 (2022).
Google Scholar
Sharma, S. et al. Yeast Kre33 and human NAT10 are conserved 18S rRNA cytosine acetyltransferases that modify tRNAs assisted by the adaptor Tan1/THUMPD1. Nucleic Acids Res. 43, 2242–2258 (2015).
Google Scholar
Arango, D. et al. Acetylation of cytidine in mRNA promotes translation efficiency. Cell 175, 1872–1886.e1824 (2018).
Google Scholar
Sas-Chen, A. et al. Dynamic RNA acetylation revealed by quantitative cross-evolutionary mapping. Nature 583, 638–643 (2020).
Google Scholar
Arango, D. et al. Direct epitranscriptomic regulation of mammalian translation initiation through N4-acetylcytidine. Mol. Cell 82, 2797–2814.e2711 (2022).
Google Scholar
Yu, X. M. et al. N4-acetylcytidine modification of lncRNA CTC-490G23.2 promotes cancer metastasis through interacting with PTBP1 to increase CD44 alternative splicing. Oncogene 42, 1101–1116 (2023).
Google Scholar
Yang, W. et al. ac4C acetylation of RUNX2 catalyzed by NAT10 spurs osteogenesis of BMSCs and prevents ovariectomy-induced bone loss. Mol. Ther. Nucleic Acids 26, 135–147 (2021).
Google Scholar
Wang, G. et al. NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression. Clin. Transl. Med. 12, e738 (2022).
Google Scholar
Feng, Z. et al. The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA. J. Hematol. Oncol. 15, 112 (2022).
Google Scholar
Zheng, X. et al. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA. Cancer Commun. 42, 1347–1366 (2022).
Jin, C. et al. Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via ac(4)C acetylation of KIF23 mRNA. J. Exp. Clin. Cancer Res. 41, 345 (2022).
Google Scholar
Liao, L. et al. Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner. Cell Res. 33, 355–371 (2023).
Google Scholar
Nance, K. D. et al. Cytidine acetylation yields a hypoinflammatory synthetic messenger RNA. Cell Chem. Biol. 29, 312–320.e317 (2022).
Google Scholar
Chang, H., Lim, J., Ha, M. & Kim, V. N. TAIL-seq: genome-wide determination of poly(A) tail length and 3’ end modifications. Mol. Cell 53, 1044–1052 (2014).
Google Scholar
Lim, J. et al. Uridylation by TUT4 and TUT7 marks mRNA for degradation. Cell 159, 1365–1376 (2014).
Google Scholar
Mullen, T. E. & Marzluff, W. F. Degradation of histone mRNA requires oligouridylation followed by decapping and simultaneous degradation of the mRNA both 5’ to 3’ and 3’ to 5’. Genes Dev 22, 50–65 (2008).
Google Scholar
Schmidt, M. J., West, S. & Norbury, C. J. The human cytoplasmic RNA terminal U-transferase ZCCHC11 targets histone mRNAs for degradation. RNA 17, 39–44 (2011).
Google Scholar
Yang, A. et al. TENT2, TUT4, and TUT7 selectively regulate miRNA sequence and abundance. Nat. Commun. 13, 5260 (2022).
Google Scholar
Yi, H. et al. PABP cooperates with the CCR4-NOT complex to promote mRNA deadenylation and block precocious decay. Mol. Cell 70, 1081–1088.e1085 (2018).
Google Scholar
Malecki, M. et al. The exoribonuclease Dis3L2 defines a novel eukaryotic RNA degradation pathway. EMBO J. 32, 1842–1854 (2013).
Google Scholar
Ustianenko, D. et al. TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. EMBO J. 35, 2179–2191 (2016).
Google Scholar
Zhao, L. W. et al. Nuclear poly(A) binding protein 1 (PABPN1) mediates zygotic genome activation-dependent maternal mRNA clearance during mouse early embryonic development. Nucleic Acids Res. 50, 458–472 (2022).
Google Scholar
Koppers-Lalic, D. et al. Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes. Cell Rep. 8, 1649–1658 (2014).
Google Scholar
Liu, X. et al. A MicroRNA precursor surveillance system in quality control of MicroRNA synthesis. Mol. Cell 55, 868–879 (2014).
Google Scholar
Ripin, N. et al. Molecular basis for AU-rich element recognition and dimerization by the HuR C-terminal RRM. Proc. Natl. Acad. Sci. USA 116, 2935–2944 (2019).
Google Scholar
Loh, X. Y. et al. RNA-binding protein ZFP36L1 suppresses hypoxia and cell-cycle signaling. Cancer Res. 80, 219–233 (2020).
Google Scholar
Rataj, F. et al. Targeting AU-rich element-mediated mRNA decay with a truncated active form of the zinc-finger protein TIS11b/BRF1 impairs major hallmarks of mammary tumorigenesis. Oncogene 38, 5174–5190 (2019).
Google Scholar
Gu, L. et al. Reconstitution of HuR-Inhibited CUGBP1 expression protects cardiomyocytes from acute myocardial infarction-induced injury. Antioxid. Redox Signal. 27, 1013–1026 (2017).
Google Scholar
Lin, C. C. et al. Terminal uridyltransferase 7 regulates TLR4-triggered inflammation by controlling Regnase-1 mRNA uridylation and degradation. Nat. Commun. 12, 3878 (2021).
Google Scholar
Heo, I. et al. TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell 138, 696–708 (2009).
Google Scholar
Rau, F. et al. Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy. Nat. Struct. Mol. Biol. 18, 840–845 (2011).
Google Scholar
Heo, I. et al. Mono-uridylation of pre-microRNA as a key step in the biogenesis of group II let-7 microRNAs. Cell 151, 521–532 (2012).
Google Scholar
Kim, H. et al. A Mechanism for microRNA Arm Switching Regulated by Uridylation. Mol. Cell 78, 1224–1236.e1225 (2020).
Google Scholar
Ansari, M. Y. et al. Genetic inactivation of ZCCHC6 suppresses interleukin-6 expression and reduces the severity of experimental osteoarthritis in mice. Arthritis Rheumatol. 71, 583–593 (2019).
Google Scholar
Nishikura, K. A-to-I editing of coding and non-coding RNAs by ADARs. Nat. Rev. Mol. Cell Biol. 17, 83–96 (2016).
Google Scholar
Chung, H. et al. Human ADAR1 prevents endogenous RNA from triggering translational shutdown. Cell 172, 811–824.e814 (2018).
Google Scholar
Chen, J. et al. Global RNA editing identification and characterization during human pluripotent-to-cardiomyocyte differentiation. Mol. Ther. Nucleic Acids 26, 879–891 (2021).
Google Scholar
Wang, F. et al. A comprehensive RNA editome reveals that edited Azin1 partners with DDX1 to enable hematopoietic stem cell differentiation. Blood 138, 1939–1952 (2021).
Google Scholar
Jiang, L. et al. ADAR1-mediated RNA editing links ganglioside catabolism to glioblastoma stem cell maintenance. J. Clin. Invest. 132, e143397 (2022).
Google Scholar
Solomon, O. et al. RNA editing by ADAR1 leads to context-dependent transcriptome-wide changes in RNA secondary structure. Nat. Commun. 8, 1440 (2017).
Google Scholar
Kokot, K. E. et al. Reduction of A-to-I RNA editing in the failing human heart regulates formation of circular RNAs. Basic Res. Cardiol. 117, 32 (2022).
Google Scholar
Zipeto, M. A. et al. ADAR1 activation drives leukemia stem cell self-renewal by impairing Let-7 biogenesis. Cell Stem Cell 19, 177–191 (2016).
Google Scholar
Wu, X. et al. ADAR2 increases in exercised heart and protects against myocardial infarction and doxorubicin-induced cardiotoxicity. Mol. Ther. 30, 400–414 (2022).
Google Scholar
Hu, X., Zou, Q., Yao, L. & Yang, X. Survey of the binding preferences of RNA-binding proteins to RNA editing events. Genome Biol. 23, 169 (2022).
Google Scholar
Stellos, K. et al. Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation. Nat. Med. 22, 1140–1150 (2016).
Google Scholar
Shen, H. et al. ADARs act as potent regulators of circular transcriptome in cancer. Nat. Commun. 13, 1508 (2022).
Google Scholar
Yang, C. C. et al. ADAR1-mediated 3’ UTR editing and expression control of antiapoptosis genes fine-tunes cellular apoptosis response. Cell Death Dis. 8, e2833 (2017).
Google Scholar
Chalk, A. M., Taylor, S., Heraud-Farlow, J. E. & Walkley, C. R. The majority of A-to-I RNA editing is not required for mammalian homeostasis. Genome Biol. 20, 268 (2019).
Google Scholar
Chan, T. H. et al. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma. Gut 63, 832–843 (2014).
Google Scholar
Chan, T. H. et al. ADAR-mediated RNA editing predicts progression and prognosis of gastric cancer. Gastroenterology 151, 637–650.e610 (2016).
Google Scholar
van der Kwast, R. et al. Adenosine-to-inosine editing of vasoactive microRNAs alters their targetome and function in ischemia. Mol. Ther. Nucleic Acids 21, 932–953 (2020).
Google Scholar
Tan, M. H. et al. Dynamic landscape and regulation of RNA editing in mammals. Nature 550, 249–254 (2017).
Google Scholar
Shiromoto, Y., Sakurai, M., Minakuchi, M., Ariyoshi, K. & Nishikura, K. ADAR1 RNA editing enzyme regulates R-loop formation and genome stability at telomeres in cancer cells. Nat. Commun. 12, 1654 (2021).
Google Scholar
Jimeno, S. et al. ADAR-mediated RNA editing of DNA:RNA hybrids is required for DNA double strand break repair. Nat. Commun. 12, 5512 (2021).
Google Scholar
Song, Y. et al. RNA editing mediates the functional switch of COPA in a novel mechanism of hepatocarcinogenesis. J. Hepatol. 74, 135–147 (2021).
Google Scholar
Chen, L. et al. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat. Med. 19, 209–216 (2013).
Google Scholar
van der Kwast, R. et al. Adenosine-to-inosine editing of microRNA-487b alters target gene selection after ischemia and promotes neovascularization. Circ. Res. 122, 444–456 (2018).
Google Scholar
Li, Q. et al. RNA editing underlies genetic risk of common inflammatory diseases. Nature 608, 569–577 (2022).
Google Scholar
Liddicoat, B. J. et al. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Science 349, 1115–1120 (2015).
Google Scholar
Garcia-Gonzalez, C. et al. ADAR1 prevents autoinflammatory processes in the heart mediated by IRF7. Circ. Res. 131, 580–597 (2022).
Google Scholar
de Reuver, R. et al. ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation. Nature 607, 784–789 (2022).
Google Scholar
Karijolich, J., Yi, C. & Yu, Y. T. Transcriptome-wide dynamics of RNA pseudouridylation. Nat. Rev. Mol. Cell Biol. 16, 581–585 (2015).
Google Scholar
Davis, D. R. Stabilization of RNA stacking by pseudouridine. Nucleic Acids Res. 23, 5020–5026 (1995).
Google Scholar
Zhao, B. S. & He, C. Pseudouridine in a new era of RNA modifications. Cell Res. 25, 153–154 (2015).
Google Scholar
Li, X. et al. Chemical pulldown reveals dynamic pseudouridylation of the mammalian transcriptome. Nat. Chem. Biol. 11, 592–597 (2015).
Google Scholar
Ni, J., Tien, A. L. & Fournier, M. J. Small nucleolar RNAs direct site-specific synthesis of pseudouridine in ribosomal RNA. Cell 89, 565–573 (1997).
Google Scholar
Ruggero, D. et al. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 299, 259–262 (2003).
Google Scholar
Li, L. & Ye, K. Crystal structure of an H/ACA box ribonucleoprotein particle. Nature 443, 302–307 (2006).
Google Scholar
Ganot, P., Bortolin, M. L. & Kiss, T. Site-specific pseudouridine formation in preribosomal RNA is guided by small nucleolar RNAs. Cell 89, 799–809 (1997).
Google Scholar
Schwartz, S. et al. Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA. Cell 159, 148–162 (2014).
Google Scholar
Dai, Q. et al. Quantitative sequencing using BID-seq uncovers abundant pseudouridines in mammalian mRNA at base resolution. Nat. Biotechnol. 41, 344–354 (2023).
Google Scholar
Bykhovskaya, Y., Casas, K., Mengesha, E., Inbal, A. & Fischel-Ghodsian, N. Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am. J. Hum. Genet. 74, 1303–1308 (2004).
Google Scholar
Shaheen, R. et al. A homozygous truncating mutation in PUS3 expands the role of tRNA modification in normal cognition. Hum. Genet. 135, 707–713 (2016).
Google Scholar
Lin, T. Y. et al. Destabilization of mutated human PUS3 protein causes intellectual disability. Hum. Mutat. 43, 2063–2078 (2022).
Google Scholar
Cui, Q. et al. Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesis. Nat Cancer 2, 932–949 (2021).
Google Scholar
Guegueniat, J. et al. The human pseudouridine synthase PUS7 recognizes RNA with an extended multi-domain binding surface. Nucleic Acids Res. 49, 11810–11822 (2021).
Google Scholar
McCleverty, C. J., Hornsby, M., Spraggon, G. & Kreusch, A. Crystal structure of human Pus10, a novel pseudouridine synthase. J. Mol. Biol. 373, 1243–1254 (2007).
Google Scholar
Song, J. et al. Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation. Nat. Chem. Biol. 16, 160–169 (2020).
Google Scholar
Jia, Z. et al. Human TRUB1 is a highly conserved pseudouridine synthase responsible for the formation of Ψ55 in mitochondrial tRNAAsn, tRNAGln, tRNAGlu and tRNAPro. Nucleic Acids Res. 50, 9368–9381 (2022).
Google Scholar
Taoka, M. et al. Landscape of the complete RNA chemical modifications in the human 80S ribosome. Nucleic Acids Res. 46, 9289–9298 (2018).
Google Scholar
Mochizuki, Y., He, J., Kulkarni, S., Bessler, M. & Mason, P. J. Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing. Proc. Natl. Acad. Sci. USA 101, 10756–10761 (2004).
Google Scholar
Nir, R. et al. A systematic dissection of determinants and consequences of snoRNA-guided pseudouridylation of human mRNA. Nucleic Acids Res. 50, 4900–4916 (2022).
Google Scholar
Antonicka, H. et al. A pseudouridine synthase module is essential for mitochondrial protein synthesis and cell viability. EMBO Rep. 18, 28–38 (2017).
Google Scholar
Carlile, T. M. et al. mRNA structure determines modification by pseudouridine synthase 1. Nat. Chem. Biol. 15, 966–974 (2019).
Google Scholar
Safra, M., Nir, R., Farouq, D., Vainberg Slutskin, I. & Schwartz, S. TRUB1 is the predominant pseudouridine synthase acting on mammalian mRNA via a predictable and conserved code. Genome Res. 27, 393–406 (2017).
Google Scholar
Levi, O. & Arava, Y. S. Pseudouridine-mediated translation control of mRNA by methionine aminoacyl tRNA synthetase. Nucleic Acids Res. 49, 432–443 (2021).
Google Scholar
Guzzi, N. et al. Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome. Nat. Cell Biol. 24, 299–306 (2022).
Google Scholar
Yoon, A. et al. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science 312, 902–906 (2006).
Google Scholar
Bellodi, C. et al. Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis. Cancer Res. 70, 6026–6035 (2010).
Google Scholar
McMahon, M. et al. A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS. Elife 8, e48847 (2019).
Google Scholar
Eyler, D. E. et al. Pseudouridinylation of mRNA coding sequences alters translation. Proc. Natl. Acad. Sci. USA 116, 23068–23074 (2019).
Google Scholar
Karijolich, J. & Yu, Y. T. Converting nonsense codons into sense codons by targeted pseudouridylation. Nature 474, 395–398 (2011).
Google Scholar
Anderson, B. R. et al. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res. 38, 5884–5892 (2010).
Google Scholar
Tan, J. et al. Noncanonical registers and base pairs in human 5’ splice-site selection. Nucleic Acids Res. 44, 3908–3921 (2016).
Google Scholar
Wu, G. et al. Pseudouridines in U2 snRNA stimulate the ATPase activity of Prp5 during spliceosome assembly. EMBO J. 35, 654–667 (2016).
Google Scholar
Martinez, N. M. et al. Pseudouridine synthases modify human pre-mRNA co-transcriptionally and affect pre-mRNA processing. Mol. Cell 82, 645–659.e649 (2022).
Google Scholar
Rapino, F. et al. Wobble tRNA modification and hydrophilic amino acid patterns dictate protein fate. Nat. Commun. 12, 2170 (2021).
Google Scholar
Rosu, A. et al. Loss of tRNA-modifying enzyme Elp3 activates a p53-dependent antitumor checkpoint in hematopoiesis. J. Exp. Med. 218, e20200662 (2021).
Google Scholar
Songe-Møller, L. et al. Mammalian ALKBH8 possesses tRNA methyltransferase activity required for the biogenesis of multiple wobble uridine modifications implicated in translational decoding. Mol. Cell. Biol. 30, 1814–1827 (2010).
Google Scholar
Delaunay, S. et al. Elp3 links tRNA modification to IRES-dependent translation of LEF1 to sustain metastasis in breast cancer. J. Exp. Med. 213, 2503–2523 (2016).
Google Scholar
Xu, S. et al. Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer. Nat. Commun. 10, 5492 (2019).
Google Scholar
Kirino, Y. et al. Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease. Proc. Natl. Acad. Sci. USA 101, 15070–15075 (2004).
Google Scholar
Kopajtich, R. et al. Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis, and encephalopathy. Am. J. Hum. Genet. 95, 708–720 (2014).
Google Scholar
Chen, D. et al. Deletion of Gtpbp3 in zebrafish revealed the hypertrophic cardiomyopathy manifested by aberrant mitochondrial tRNA metabolism. Nucleic Acids Res. 47, 5341–5355 (2019).
Google Scholar
Sasarman, F., Antonicka, H., Horvath, R. & Shoubridge, E. A. The 2-thiouridylase function of the human MTU1 (TRMU) enzyme is dispensable for mitochondrial translation. Hum. Mol. Genet. 20, 4634–4643 (2011).
Google Scholar
Bilbille, Y. et al. The human mitochondrial tRNAMet: structure/function relationship of a unique modification in the decoding of unconventional codons. J. Mol. Biol. 406, 257–274 (2011).
Google Scholar
Cantara, W. A., Murphy, F. V. T., Demirci, H. & Agris, P. F. Expanded use of sense codons is regulated by modified cytidines in tRNA. Proc. Natl. Acad. Sci. USA 110, 10964–10969 (2013).
Google Scholar
Tsao, C. W. et al. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation 147, e93–e621 (2023).
Google Scholar
Roth, G. A. et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J. Am. Coll. Cardiol. 70, 1–25 (2017).
Google Scholar
Zhou, B., Perel, P., Mensah, G. A. & Ezzati, M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 18, 785–802 (2021).
Google Scholar
Libby, P. et al. Atherosclerosis. Nat. Rev. Dis. Primers 5, 56 (2019).
Google Scholar
Touyz, R. M. et al. Vascular smooth muscle contraction in hypertension. Cardiovasc. Res. 114, 529–539 (2018).
Google Scholar
Jain, M. et al. RNA editing of Filamin A pre-mRNA regulates vascular contraction and diastolic blood pressure. EMBO J. 37, e94813 (2018).
Google Scholar
Marcadenti, A. et al. Effects of FTO RS9939906 and MC4R RS17782313 on obesity, type 2 diabetes mellitus and blood pressure in patients with hypertension. Cardiovasc. Diabetol. 12, 103 (2013).
Google Scholar
Liu, S. et al. HuR (Human Antigen R) regulates the contraction of vascular smooth muscle and maintains blood pressure. Arterioscler. Thromb. Vasc. Biol. 40, 943–957 (2020).
Google Scholar
Klöss, S., Rodenbach, D., Bordel, R. & Mülsch, A. Human-antigen R (HuR) expression in hypertension: downregulation of the mRNA stabilizing protein HuR in genetic hypertension. Hypertension 45, 1200–1206 (2005).
Google Scholar
Chien, C. S. et al. METTL3-dependent N(6)-methyladenosine RNA modification mediates the atherogenic inflammatory cascades in vascular endothelium. Proc. Natl. Acad. Sci. USA 118, e2025070118 (2021).
Google Scholar
Jian, D. et al. METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications. Theranostics 10, 8939–8956 (2020).
Google Scholar
Zheng, Y. et al. Mettl14 mediates the inflammatory response of macrophages in atherosclerosis through the NF-κB/IL-6 signaling pathway. Cell. Mol. Life Sci. 79, 311 (2022).
Google Scholar
Vlachogiannis, N. I. et al. Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease. J. Mol. Cell. Cardiol. 160, 111–120 (2021).
Google Scholar
Sun, Z. et al. Matr3 reshapes m6A modification complex to alleviate macrophage inflammation during atherosclerosis. Clin. Immunol. 245, 109176 (2022).
Google Scholar
Zhang, X., Li, X., Jia, H., An, G. & Ni, J. The m(6)A methyltransferase METTL3 modifies PGC-1α mRNA promoting mitochondrial dysfunction and oxLDL-induced inflammation in monocytes. J. Biol. Chem. 297, 101058 (2021).
Google Scholar
Chen, J. et al. METTL14-dependent m6A regulates vascular calcification induced by indoxyl sulfate. Life Sci 239, 117034 (2019).
Google Scholar
Zhou, T. et al. Factors influencing osteogenic differentiation of human aortic valve interstitial cells. J. Thorac. Cardiovasc. Surg. 161, e163–e185 (2021).
Google Scholar
Wang, K. et al. PIWI-interacting RNA HAAPIR regulates cardiomyocyte death after myocardial infarction by promoting NAT10-mediated ac(4) C acetylation of Tfec mRNA. Adv. Sci. 9, e2106058 (2022).
Mathiyalagan, P. et al. FTO-dependent N(6)-methyladenosine regulates cardiac function during remodeling and repair. Circulation 139, 518–532 (2019).
Google Scholar
Han, Z. et al. ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1. Theranostics 11, 3000–3016 (2021).
Google Scholar
Sun, P. et al. Extracellular vesicle-packaged mitochondrial disturbing miRNA exacerbates cardiac injury during acute myocardial infarction. Clin. Transl. Med. 12, e779 (2022).
Google Scholar
Song, H. et al. METTL3 and ALKBH5 oppositely regulate m(6)A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes. Autophagy 15, 1419–1437 (2019).
Google Scholar
Wang, L. et al. METTL14 is required for exercise-induced cardiac hypertrophy and protects against myocardial ischemia-reperfusion injury. Nat. Commun. 13, 6762 (2022).
Google Scholar
McKenna, W. J., Maron, B. J. & Thiene, G. Classification, epidemiology, and global burden of cardiomyopathies. Circ. Res. 121, 722–730 (2017).
Google Scholar
Maron, B. J. & Maron, M. S. Hypertrophic cardiomyopathy. Lancet 381, 242–255 (2013).
Google Scholar
Schultheiss, H. P. et al. Dilated cardiomyopathy. Nat. Rev. Dis. Primers 5, 32 (2019).
Google Scholar
Muchtar, E., Blauwet, L. A. & Gertz, M. A. Restrictive cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ. Res. 121, 819–837 (2017).
Google Scholar
Ghezzi, D. et al. Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis. Am. J. Hum. Genet. 90, 1079–1087 (2012).
Google Scholar
Perks, K. L. et al. PTCD1 is required for 16S rRNA maturation complex stability and mitochondrial ribosome assembly. Cell Rep 23, 127–142 (2018).
Google Scholar
Gao, S. et al. Depletion of m(6) A reader protein YTHDC1 induces dilated cardiomyopathy by abnormal splicing of Titin. J. Cell. Mol. Med. 25, 10879–10891 (2021).
Google Scholar
Meng, L. et al. METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA. Cell Death Dis. 13, 38 (2022).
Google Scholar
Peng, T. et al. LncRNA Airn alleviates diabetic cardiac fibrosis by inhibiting activation of cardiac fibroblasts via a m6A-IMP2-p53 axis. Biol. Direct 17, 32 (2022).
Google Scholar
Zhuang, S. et al. METTL14 promotes doxorubicin-induced cardiomyocyte ferroptosis by regulating the KCNQ1OT1-miR-7-5p-TFRC axis. Cell Biol Toxicol. (2021).
Nakamura, M. & Sadoshima, J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat. Rev. Cardiol. 15, 387–407 (2018).
Google Scholar
Berulava, T. et al. Changes in m6A RNA methylation contribute to heart failure progression by modulating translation. Eur. J. Heart Fail. 22, 54–66 (2020).
Google Scholar
Zhang, B. et al. m6A demethylase FTO attenuates cardiac dysfunction by regulating glucose uptake and glycolysis in mice with pressure overload-induced heart failure. Signal Transduct. Target. Ther. 6, 377 (2021).
Google Scholar
Dorn, L. E. et al. The N(6)-methyladenosine mRNA methylase METTL3 controls cardiac homeostasis and hypertrophy. Circulation 139, 533–545 (2019).
Google Scholar
Gao, X. Q. et al. The piRNA CHAPIR regulates cardiac hypertrophy by controlling METTL3-dependent N(6)-methyladenosine methylation of Parp10 mRNA. Nat. Cell Biol. 22, 1319–1331 (2020).
Google Scholar
Xu, H. et al. YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoy. Cell Biosci. 11, 132 (2021).
Google Scholar
Hoeper, M. M. et al. A global view of pulmonary hypertension. Lancet Respir. Med. 4, 306–322 (2016).
Google Scholar
Schermuly, R. T., Ghofrani, H. A., Wilkins, M. R. & Grimminger, F. Mechanisms of disease: pulmonary arterial hypertension. Nat. Rev. Cardiol. 8, 443–455 (2011).
Google Scholar
Hu, L. et al. YTHDF1 regulates pulmonary hypertension through translational control of MAGED1. Am. J. Respir. Crit. Care Med. 203, 1158–1172 (2021).
Google Scholar
Liu, P. et al. m(6)A modification-mediated GRAP regulates vascular remodeling in hypoxic pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 67, 574–588 (2022).
Google Scholar
Hu, L. et al. Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages. Redox Biol. 61, 102638 (2023).
Google Scholar
Blackwell, D. J., Schmeckpeper, J. & Knollmann, B. C. Animal models to study cardiac arrhythmias. Circ. Res. 130, 1926–1964 (2022).
Google Scholar
Herring, N., Kalla, M. & Paterson, D. J. The autonomic nervous system and cardiac arrhythmias: current concepts and emerging therapies. Nat. Rev. Cardiol. 16, 707–726 (2019).
Google Scholar
Qi, L. et al. m(6)A methyltransferase METTL3 participated in sympathetic neural remodeling post-MI via the TRAF6/NF-κB pathway and ROS production. J. Mol. Cell. Cardiol. 170, 87–99 (2022).
Google Scholar
Qi, L. et al. New insights into the central sympathetic hyperactivity post-myocardial infarction: Roles of METTL3-mediated m(6) A methylation. J. Cell. Mol. Med. 26, 1264–1280 (2022).
Google Scholar
Zhou, Y. et al. METTL3 boosts glycolysis and cardiac fibroblast proliferation by increasing AR methylation. Int. J. Biol. Macromol. 223, 899–915 (2022).
Google Scholar
Nienaber, C. A. et al. Aortic dissection. Nat. Rev. Dis. Primers 2, 16053 (2016).
Google Scholar
Li, N. et al. Targeting ferroptosis as a novel approach to alleviate aortic dissection. Int. J. Biol. Sci. 18, 4118–4134 (2022).
Google Scholar
Xin, M., Olson, E. N. & Bassel-Duby, R. Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair. Nat. Rev. Mol. Cell. Biol. 14, 529–541 (2013).
Google Scholar
Wang, Y. et al. Mutations in RNA methyltransferase gene NSUN5 confer high risk of outflow tract malformation. Front. Cell Dev. Biol. 9, 623394 (2021).
Google Scholar
Moore, J. B. T. et al. The A-to-I RNA editing enzyme Adar1 is essential for normal embryonic cardiac growth and development. Circ. Res. 127, 550–552 (2020).
Google Scholar
Han, Z. et al. ALKBH5-mediated m(6)A mRNA methylation governs human embryonic stem cell cardiac commitment. Mol. Ther. Nucleic Acids 26, 22–33 (2021).
Google Scholar
Yang, Y. et al. Dynamic patterns of N6-methyladenosine profiles of messenger RNA correlated with the cardiomyocyte regenerability during the early heart development in mice. Oxid. Med. Cell. Longev. 2021, 5537804 (2021).
Google Scholar
Wang, S. et al. Differential roles of YTHDF1 and YTHDF3 in embryonic stem cell-derived cardiomyocyte differentiation. RNA Biol. 18, 1354–1363 (2021).
Google Scholar
Qian, B., Wang, P., Zhang, D. & Wu, L. m6A modification promotes miR-133a repression during cardiac development and hypertrophy via IGF2BP2. Cell Death Discov. 7, 157 (2021).
Google Scholar
Gong, R. et al. Loss of m(6)A methyltransferase METTL3 promotes heart regeneration and repair after myocardial injury. Pharmacol. Res. 174, 105845 (2021).
Google Scholar
Jiang, F. Q. et al. Mettl3-mediated m(6)A modification of Fgf16 restricts cardiomyocyte proliferation during heart regeneration. Elife 11, e77014 (2022).
Google Scholar
Zhao, Y. et al. Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A. Clin. Transl. Med. 11, e402 (2021).
Google Scholar
Hashimoto, H., Olson, E. N. & Bassel-Duby, R. Therapeutic approaches for cardiac regeneration and repair. Nat. Rev. Cardiol. 15, 585–600 (2018).
Google Scholar
Del Re, D. P., Amgalan, D., Linkermann, A., Liu, Q. & Kitsis, R. N. Fundamental mechanisms of regulated cell death and implications for heart disease. Physiol. Rev. 99, 1765–1817 (2019).
Google Scholar
Cheng, P. et al. Amelioration of acute myocardial infarction injury through targeted ferritin nanocages loaded with an ALKBH5 inhibitor. Acta Biomater. 140, 481–491 (2022).
Google Scholar
Liu, K. et al. Exercise training ameliorates myocardial phenotypes in heart failure with preserved ejection fraction by changing N6-methyladenosine modification in mice model. Front. Cell Dev. Biol. 10, 954769 (2022).
Google Scholar
Yang, Q. et al. Exercise mitigates endothelial pyroptosis and atherosclerosis by downregulating NEAT1 through N6-methyladenosine modifications. Arterioscler. Thromb Vasc. Biol. 43, 910–926 (2023).
Google Scholar
Xu, Z., Qin, Y., Lv, B., Tian, Z. & Zhang, B. Intermittent fasting improves high-fat diet-induced obesity cardiomyopathy via alleviating lipid deposition and apoptosis and decreasing m6A methylation in the heart. Nutrients 14, 251 (2022).
Google Scholar
Wang, X., Li, Y., Li, J., Li, S. & Wang, F. Mechanism of METTL3-mediated m(6)A modification in cardiomyocyte pyroptosis and myocardial ischemia-reperfusion injury. Cardiovasc. Drugs Ther. 37, 435–448 (2023).
Google Scholar
Zhang, R. et al. METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221/222 maturation in an m6A-dependent manner. Cell. Mol. Biol. Lett. 27, 55 (2022).
Google Scholar
Li, T. et al. Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts. FASEB J. 35, e21162 (2021).
Google Scholar
Fang, Z. M. et al. Methyltransferase-like 3 suppresses phenotypic switching of vascular smooth muscle cells by activating autophagosome formation. Cell Prolif. 56, e13386 (2023).
Google Scholar
Shen, L. et al. Nine-month angiographic and two-year clinical follow-up of novel biodegradable-polymer arsenic trioxide-eluting stent versus durable-polymer sirolimus-eluting stent for coronary artery disease. Chin. Med. J. (Engl) 128, 768–773 (2015).
Google Scholar
Yu, H. et al. Arsenic trioxide activates yes-associated protein by lysophosphatidic acid metabolism to selectively induce apoptosis of vascular smooth muscle cells. Biochim. Biophys. Acta Mol. Cell Res. 1869, 119211 (2022).
Google Scholar
Fang, M., Deng, J., Zhou, Q., Hu, Z. & Yang, L. Maslinic acid protects against pressure-overload-induced cardiac hypertrophy by blocking METTL3-mediated m(6)A methylation. Aging (Albany N. Y.) 14, 2548–2557 (2022).
Google Scholar
Zhang, M. et al. Tanshinone IIA alleviates cardiac hypertrophy through m6A modification of galectin-3. Bioengineered 13, 4260–4270 (2022).
Google Scholar
Seo, K. W. & Kleiner, R. E. YTHDF2 recognition of N(1)-methyladenosine (m(1)A)-modified RNA is associated with transcript destabilization. ACS Chem. Biol. 15, 132–139 (2020).
Google Scholar
Dai, X., Wang, T., Gonzalez, G. & Wang, Y. Identification of YTH domain-containing proteins as the readers for N1-methyladenosine in RNA. Anal. Chem. 90, 6380–6384 (2018).
Google Scholar
Zheng, Q. et al. Cytoplasmic m(1)A reader YTHDF3 inhibits trophoblast invasion by downregulation of m(1)A-methylated IGF1R. Cell Discov. 6, 12 (2020).
Google Scholar
Boo, S. H., Ha, H. & Kim, Y. K. m(1)A and m(6)A modifications function cooperatively to facilitate rapid mRNA degradation. Cell Rep. 40, 111317 (2022).
Google Scholar
Olsen, M. B. et al. NEIL3-dependent regulation of cardiac fibroblast proliferation prevents myocardial rupture. Cell Rep. 18, 82–92 (2017).
Google Scholar
Tabish, A. M. et al. Association of intronic DNA methylation and hydroxymethylation alterations in the epigenetic etiology of dilated cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 317, H168–h180 (2019).
Google Scholar
Leopold, J. A. & Loscalzo, J. Emerging role of precision medicine in cardiovascular disease. Circ. Res. 122, 1302–1315 (2018).
Google Scholar
Ylä-Herttuala, S. & Baker, A. H. Cardiovascular gene therapy: past, present, and future. Mol. Ther. 25, 1095–1106 (2017).
Google Scholar
Saeed, S. et al. Nanoparticle: a promising player in nanomedicine and its theranostic applications for the treatment of cardiovascular diseases. Curr. Probl. Cardiol. 48, 101599 (2023).
Google Scholar
